Generable

Generable provides a cutting-edge computational oncology platform designed for biotechs, pharmaceutical companies, and hospitals, aiming to decrease treatment failure rates in clinical trials and practice by predicting individual disease progression based on various therapeutic options. Founded by the core developers of the Stan language, the compa... ny specializes in Bayesian methods for model development, optimization, and training, addressing complex questions in clinical trial design and treatment efficacy. Their approach emphasizes explainability and transparency, utilizing advanced algorithms and calibration techniques to enhance predictive accuracy, even in scenarios with limited data. Generable's innovative solutions are particularly beneficial for early clinical trials and rare diseases, leveraging prior knowledge to inform predictions and outcomes.Read More